Artesian Resources Corporation filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, reporting increased revenues and net income compared with the same periods in 2025.
Director Lindsay Hyde filed a Form 4 with the SEC on August 12, 2026, reporting the acquisition of 11,149 shares of Monro, Inc. common stock through a restricted stock award dated August 11, 2026.
Director Leah C. Johnson filed a Form 4 with the SEC on August 12, 2026, reporting the acquisition of restricted common stock of Monro, Inc. on August 11, 2026.
A statement of changes in beneficial ownership filed on August 12, 2026 discloses that David C. Kimbell, a director of Group 1 Automotive Inc (NYSE:GPI), acquired 336 restricted stock units on August 10, 2026.
Robert W. McMahon, SVP and Chief Financial Officer of West Pharmaceutical Services Inc, filed a Form 4 on August 12, 2026, disclosing restricted stock unit vesting and related share withholding transactions dated August 11, 2026.
Andre Spolidoro Ferreira Gomes, Chief Strategy Officer of VTEX, filed a Form 4 on August 12, 2026, disclosing the sale of 15,000 Class A Common Shares on August 10, 2026.
Kimberly A. Kuryea, Senior Vice President and CFO of General Dynamics Corp, filed a Form 4 on August 12, 2026, reporting transactions in the company's common stock dated August 10, 2026.
Director Joshua Bershad filed a Form 4 with the SEC on August 12, 2026, disclosing a disposition of 6,900 shares of Middlesex Water Co common stock on August 11, 2026, via a trust distribution at a price of $0.
A Form 4 filed on August 12, 2026, reported that Peter A. Wall, a director of General Dynamics Corp, exercised stock options and sold shares of common stock on August 10, 2026.
Robert J. More, a director of Vir Biotechnology, Inc. (NASDAQ:VIR), filed a Form 4 on August 12, 2026, reporting a transaction dated August 11, 2026, in which 8,000 shares of common stock were transferred to Alta Partners NextGen Fund I, L.P. at no consideration …